Washington Vertex Pharmaceuticals - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

CBS News 8 · 9m

FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

WASHINGTON — Federal officials on Thursday approved ... The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach ...

Hosted on MSN · 2h

FDA OK's painkiller designed to end opioids' addiction and overdose risk

Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.

CNBC on MSN · 17h

FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.

20hon MSN

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)’s Suzetrigine: ‘I Don’t See A Lot Of Upside Because That Was The Drug Of The Future For Vertex’

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

1h

Vertex Pharmaceuticals price target raised to $433 from $430 at Scotiabank

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $433 from $430 and keeps a Sector Perform rating on the shares.

NBC News on MSN13d

'Will it really work?': Young sickle cell patient among the first to start new gene therapy

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results